-- 根據FactSet調查的分析師報告，百健（Biogen，股票代碼：BIIB）的平均評級為“增持”，平均目標價為215.86美元。 （報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們：https://www..com/contact-us）
Price: $191.77, Change: $-2.61, Percent Change: -1.34%
Related Articles
Mining & Metals
Air Canada Suspended FY26 Guidance and Introduced Q2 2026 Financial Guidance "Providing Near-term Visibility"
$AC.TO
Australia
Earnings Flash (AAPL) Apple Posts Fiscal Q2 EPS $2.01, vs. FactSet Est of $1.95
Price: $271.83, Change: $+1.66, Percent Change: +0.61%
$AAPL
Mining & Metals
Air Canada Says Delivered Record Q1 Operating Revenues of $5.8 Billion
$AC.TO